Key result
A nomogram combining hypertension, diabetes, and urinary albumin accurately predicts CKD stage 1 progression.
Why the study?
Chronic kidney disease progression substantially affects patient survival and living standards, prompting the need to analyze risk factors for CKD stage 1 progression.
Can a nomogram based on clinical data and peripheral blood samples accurately predict the progression of CKD stage 1?
Cohort (n=300)
Can a nomogram based on clinical data and peripheral blood samples accurately predict the progression of CKD stage 1?
A nomogram incorporating hypertension, diabetes, and urinary albumin can accurately predict the progression of CKD stage 1, potentially aiding in personalized clinical decision making.
May aid risk stratification in CKD stage 1; leaves open need for external validation before clinical adoption.
Patients with chronic kidney disease (CKD) have high morbidity and mortality, and the disease progression has a significant impact on their survival and living standards.This research aims to analyze risk factors for CKD stage 1 and provide a reference for clinical decision making.The clinical data and peripheral blood samples of 300 patients with CKD stage 1 were collected retrospectively.Patients were randomly assigned into a training set (n = 210) and a validation set (n = 90).Patients' baseline characteristic levels were subjected to statistical tests for difference.Univariate and multivariate Cox regression analyses were utilized to identify risk factors influencing disease progression.Subsequently, a prediction model for disease progression was developed using a nomogram, and the model's accuracy was assessed using the C-index and calibration curve.The results revealed that hypertension, diabetes, and urinary albumin were essential factors in the progression of CKD stage 1.The nomogram was constructed and then the C-index was calculated.The calibration curve was utilized to assess the risk model.The C-index of the training set was 0.75, and the C-index of the validation set was 0.73, suggesting a good predictive ability of the model.The risk model accurately predicted the progression of CKD stage 1, which is of great significance to developing personalized treatment for patients in clinical practice.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) conducted a cohort in Chronic kidney disease stage 1 (n=300). Risk prediction nomogram was evaluated on Progression of CKD stage 1. A nomogram incorporating hypertension, diabetes, and urinary albumin accurately predicted the progression of CKD stage 1, with a C-index of 0.75 in the training set and 0.73 in the validation set.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: